Causey Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$453K Hold
7,262
– – 0.17% 59
2026
Q2
$418K Hold
7,262
– – 0.16% 61
2026
Q1
$440K Hold
7,262
– – 0.19% 57
2025
Q4
$392K Buy
7,262
+407
+6% +$19.6K 0.18% 54
2025
Q3
$309K Hold
6,855
– – 0.15% 55
2025
Q2
$317K Sell
6,855
-79
-1% -$3.88K 0.16% 53
2025
Q1
$423K Hold
6,934
– – 0.24% 45
2024
Q4
$392K Buy
+6,934
New +$387K 0.23% 45

Other funds holding BMY

Causey Wealth's BMY Position: Q3 2026 in Review

Causey Wealth held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 7,262 shares worth $453K. The position accounts for 0.17% of the portfolio, ranked #59.

Causey Wealth first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Causey Wealth held 7,262 shares of Bristol-Myers Squibb worth $453K as of Q3 2026.
  • Causey Wealth left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.17% of Causey Wealth's portfolio in Q3 2026, its #59 holding.
  • Causey Wealth first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Causey Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.